News roundup Tuesday, May 21

The latest from BioStock

» Prolights Diagnostics CTO delighted to receive UK government grant
» Iconovo begins development of inhaled obesity treatment
» Issuance drives Annexin's progress towards Phase II results
» Moberg's CEO on the launch of Terclara
» CLS launches in France

Read BioStock's weekly newsletter for v.20 here.

The latest news of the day

announces ambition to launch 20 new medicines and reach USD 80 billion in total revenue by 2030 and continued growth thereafter. Read more.

Alzinova announces that the first patient has been dosed with a higher dose of ALZ-101 in the phase Ib study. Read more.

BiBBInstruments is carrying out a directed new share issue of SEK 10,0 million. Read more.

BrainCool announces final outcome in oversubscribed rights issue corresponding to previously announced preliminary outcome. Read more.

Alligator Bioscience announces publication of article highlighting the potential of next-generation CD40 agonists. Read moreIt is also announced that Henlius Biotech received approval from the FDA to initiate a phase III study to evaluate HLX22 (AC101). Read more.

InDex Pharmaceuticals has entered into a conditional reverse acquisition agreement for Flerie Invest. Read more.

CLS focuses on the neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings. Read more.

Inhalation Sciences receives new order worth 60 euros from long-term big pharma customer. Read more.

AcuCort announces that a study on patients' willingness to pay has been published in an international scientific journal. Read more.

Acarix CPT III code removed from United Healthcare Medicare Advantage Noncovered List. Read more.

Dignity signs exclusivity agreement for Japan with Konica Minolta. Read more.

Micropos Medical announces more scientific advances for Raypilot. Read more.

Immunovia carries out a rights issue of units of approximately SEK 70 million and raises a bridge loan. Read more.

Magle Group does not complete the public takeover offer to the shareholders of Amniotic. Read more.

Xspray Pharma appoints Chief Operating Officer and makes changes to the management team. Read more.

Ortivus announces that the contract for the delivery of MobiMed to the Norrbotten Region has been signed. Read moreA contract has also been awarded for the delivery of MobiMed enRoute to the Örebro Region. Read more.

Eurocine Vaccines announces the outcome of the exercise of warrants of series TO 5. Read more.

Odinwell develops sensors for bacterial growth. Read more.

AegirBio successfully completes another milestone in RADx tech-program. Read more.

Peptonic Medical announces changes in the organization. Read more.

Teva and Alvotech announces that the injection of SWIMLAND (adalimumab-ryvk) is now available in the United States. Read more.

Alan Donze has been appointed as the new CEO of Bioretec. Read more.

AlzeCure average outcome in rights issue. Read more.

The shares in Lifecare are traded from today, May 21, excluding the right to receive subscription rights in the rights issue. Read more.